INHIBITION OF THE METABOLISM OF CYCLOSPORINE BY HUMAN LIVER-MICROSOMES BY FK506

被引:20
|
作者
BURKE, MD
OMAR, G
THOMSON, AW
WHITING, PH
机构
[1] UNIV ABERDEEN,SCH MED,DEPT PATHOL,IMMUNOPATHOL LAB,ABERDEEN AB9 2ZD,SCOTLAND
[2] UNIV ABERDEEN,SCH MED,DEPT CLIN BIOCHEM,ABERDEEN AB9 2ZD,SCOTLAND
关键词
D O I
10.1097/00007890-199011000-00035
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:901 / 902
页数:2
相关论文
共 50 条
  • [1] FK506 INHIBITION OF CYCLOSPORINE METABOLISM BY HUMAN LIVER-MICROSOMES
    OMAR, G
    SHAH, IA
    THOMSON, AW
    WHITING, PH
    BURKE, MD
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 934 - 935
  • [2] EFFECTS OF 23 DRUGS ON THE METABOLISM OF FK506 BY HUMAN LIVER-MICROSOMES
    IWASAKI, K
    MATSUDA, H
    NAGASE, K
    SHIRAGA, T
    TOKUMA, Y
    UCHIDA, K
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1993, 82 (02): : 209 - 216
  • [3] INHIBITION OF DRUG-METABOLISM IN RAT AND HUMAN LIVER-MICROSOMES BY FK-506 AND CYCLOSPORINE
    MOOCHHALA, SM
    LEE, EJD
    EARNEST, L
    WONG, JYY
    NGOI, SS
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (06) : 2786 - 2788
  • [4] ADRENOCHROME REACTION IMPLICATES OXYGEN RADICALS IN METABOLISM OF CYCLOSPORINE-A AND FK-506 IN RAT AND HUMAN LIVER-MICROSOMES
    AHMED, SS
    STROBEL, HW
    NAPOLI, KL
    GREVEL, J
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1993, 265 (03): : 1047 - 1054
  • [5] CYCLOSPORINE METABOLISM IN HUMAN LIVER-MICROSOMES AND ITS INHIBITION BY OTHER DRUGS
    HENRICSSON, S
    LINDHOLM, A
    ARAVOGLOU, M
    PHARMACOLOGY & TOXICOLOGY, 1990, 66 (01): : 49 - 52
  • [6] METABOLISM OF FK506, A POTENT IMMUNOSUPPRESSIVE AGENT, BY CYTOCHROME-P450 3A ENZYMES IN RAT, DOG AND HUMAN LIVER-MICROSOMES
    SHIRAGA, T
    MATSUDA, H
    NAGASE, K
    IWASAKI, K
    NODA, K
    YAMAZAKI, H
    SHIMADA, T
    FUNAE, Y
    BIOCHEMICAL PHARMACOLOGY, 1994, 47 (04) : 727 - 735
  • [7] Tacrolimus (FK506) is superior to cyclosporine in liver transplantation
    Busuttil, RW
    Holt, CD
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 534 - 538
  • [8] Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A
    A. Monegal
    M. Navasa
    N. Guañabens
    P. Peris
    F. Pons
    M. J. Martínez de Osaba
    A. Rimola
    J. Rodés
    J. Muñoz-Gómez
    Calcified Tissue International, 2001, 68 : 83 - 86
  • [9] Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A
    Monegal, A
    Navasa, M
    Guañabens, N
    Peris, P
    Pons, F
    de Osaba, MJM
    Rimola, A
    Rodés, J
    Muñoz-Gómez, J
    CALCIFIED TISSUE INTERNATIONAL, 2001, 68 (02) : 83 - 86
  • [10] Inhibition of iNOS induction by FK506, but not by cyclosporine, in rat hepatocytes
    Kaibori, M
    Okumura, T
    Ito, S
    Oda, M
    Inoue, T
    Kamiyama, Y
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 804 - 805